Been a while but last time I checked NOTHING was happening with Tovaxin but low and behold I read the "Motivator" and saw this:
During the coming year, we anticipate that other new oral medications will be submitted for evaluation and potential approval by the FDA, including teriflunomide, laquinimod, and dimethyl fumarate (BG-12). One new injectible, Lemtrada® (alemtuzumab, formerly known as Campath and given via intravenous injection), may also enter or complete the approval process. Several more injectible drugs are also on the horizon, such as ocrelizumab, daclizumab, and Tovaxin®.
What the hell did I miss? I guess I have been to involved with anti-Lingo to notice but I'm a little dumbfounded.